← United States · Coverage record
US · SEC FORM 4
Clene Inc.
CLNN · Nasdaq · CIK 0001822791 · Healthcare · Packaged Foods
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
11 Form 4 transaction lines observed in the same window
8 sales · 3 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-01-13 · MATLIN DAVID J.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 880,688
- Previous report
- 915,634
- Avg daily volume
- 117,415
- Days to cover
- 7.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-01-13 | MATLIN DAVID J | Purchase (P) | common stock | 33,333 | USD 6.50 | USD 216,664 | SEC filing ↗ |
| 2024-09-30 | MATLIN DAVID J | Purchase (P) | Common Stock | 92,307 | USD 4.75 | USD 438,458 | SEC filing ↗ |
| 2024-09-30 | Mortenson Mark | Purchase (P) | Common Stock | 20,512 | USD 4.75 | USD 97,432 | SEC filing ↗ |
| 2024-09-30 | Etherington Robert Dee | Purchase (P) | Common Stock | 10,000 | USD 4.75 | USD 47,500 | SEC filing ↗ |
| 2023-11-10 | MATLIN DAVID J | Purchase (P) | Common Stock | 250,002 | USD 0.41 | USD 102,501 | SEC filing ↗ |
| 2023-06-26 | Stevens John Henry | Purchase (P) | Common Stock | 316,455 | USD 0.80 | USD 253,164 | SEC filing ↗ |
| 2023-06-26 | Etherington Robert Dee | Purchase (P) | Common Stock | 25,000 | USD 0.81 | USD 20,250 | SEC filing ↗ |
| 2023-06-16 | Ugwumba Chidozie | Purchase (P) | Common Stock | 7,500,000 | USD 0.80 | USD 6,000,000 | SEC filing ↗ |
| 2023-06-16 | Mosca Alison | Purchase (P) | Common Stock | 2,394,375 | USD 0.80 | USD 1,915,500 | SEC filing ↗ |
| 2023-06-16 | MATLIN DAVID J | Purchase (P) | Common Stock | 1,500,000 | USD 0.80 | USD 1,200,000 | SEC filing ↗ |
| 2023-06-16 | Gay Jonathon | Purchase (P) | Common Stock | 105,625 | USD 0.80 | USD 84,500 | SEC filing ↗ |
| 2022-11-02 | Ugwumba Chidozie | Purchase (P) | Common Stock | 990,099 | USD 1.01 | USD 1,000,000 | SEC filing ↗ |
| 2022-11-02 | Stevens John Henry | Purchase (P) | Common Stock | 148,515 | USD 1.01 | USD 150,000 | SEC filing ↗ |
| 2022-11-02 | Mosca Alison | Purchase (P) | Common Stock | 792,079 | USD 1.01 | USD 800,000 | SEC filing ↗ |
| 2022-11-02 | MATLIN DAVID J | Purchase (P) | Common Stock | 2,871,287 | USD 1.01 | USD 2,900,000 | SEC filing ↗ |
Form 4 evidence
69 transaction lines in the latest 365-day window; 152 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Mosca Alison | Award / grant (A) | common stock | 198,171 | USD 3.28 | USD 650,001 | SEC filing ↗ |
| 2026-09-16 | MATLIN DAVID J | Award / grant (A) | common stock | 434,451 | USD 3.28 | USD 1,424,999 | SEC filing ↗ |
| 2026-09-16 | Etherington Robert Dee | Award / grant (A) | common stock | 15,244 | USD 3.28 | USD 50,000 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-16 | Mosca Alison | Award / grant (A) | common stock | 198,171 | USD 3.28 | USD 650,001 | SEC filing ↗ |
| 2026-09-16 | MATLIN DAVID J | Award / grant (A) | common stock | 434,451 | USD 3.28 | USD 1,424,999 | SEC filing ↗ |
| 2026-09-16 | Etherington Robert Dee | Award / grant (A) | common stock | 15,244 | USD 3.28 | USD 50,000 | SEC filing ↗ |
| 2026-05-12 | Ugwumba Chidozie | Sale (S) | Common Stock | 73,296 | USD 6.20 | USD 454,435 | SEC filing ↗ |
| 2026-05-11 | Ugwumba Chidozie | Sale (S) | Common Stock | 22,177 | USD 6.75 | USD 149,695 | SEC filing ↗ |
| 2026-05-04 | Ugwumba Chidozie | Sale (S) | Common Stock | 72,884 | USD 6.80 | USD 495,611 | SEC filing ↗ |
| 2026-05-01 | Ugwumba Chidozie | Sale (S) | Common Stock | 5,795 | USD 6.01 | USD 34,828 | SEC filing ↗ |
| 2026-04-30 | Ugwumba Chidozie | Sale (S) | Common Stock | 5,736 | USD 6.08 | USD 34,875 | SEC filing ↗ |
| 2026-04-29 | Ugwumba Chidozie | Sale (S) | Common Stock | 12,170 | USD 5.63 | USD 68,517 | SEC filing ↗ |
| 2026-04-28 | Ugwumba Chidozie | Sale (S) | Common Stock | 1,591 | USD 5.90 | USD 9,387 | SEC filing ↗ |
| 2026-04-21 | Ugwumba Chidozie | Sale (S) | Common Stock | 61,345 | USD 6.14 | USD 376,658 | SEC filing ↗ |
| 2026-04-20 | Ugwumba Chidozie | Sale (S) | Common Stock | 4,318 | USD 6.12 | USD 26,426 | SEC filing ↗ |
| 2026-04-17 | Ugwumba Chidozie | Sale (S) | Common Stock | 25,040 | USD 6.43 | USD 161,007 | SEC filing ↗ |
| 2026-04-16 | Ugwumba Chidozie | Sale (S) | Common Stock | 7,748 | USD 6.40 | USD 49,587 | SEC filing ↗ |
| 2026-04-15 | Ugwumba Chidozie | Sale (S) | Common Stock | 6,374 | USD 6.48 | USD 41,304 | SEC filing ↗ |
| 2026-04-02 | Ugwumba Chidozie | Sale (S) | Common Stock | 24,925 | USD 4.81 | USD 119,889 | SEC filing ↗ |
| 2026-04-01 | Ugwumba Chidozie | Sale (S) | Common Stock | 4,278 | USD 4.97 | USD 21,262 | SEC filing ↗ |
| 2026-03-31 | Ugwumba Chidozie | Sale (S) | Common Stock | 67,991 | USD 4.88 | USD 331,796 | SEC filing ↗ |
| 2026-03-30 | Ugwumba Chidozie | Sale (S) | Common Stock | 15,536 | USD 5.10 | USD 79,234 | SEC filing ↗ |
| 2026-03-27 | Ugwumba Chidozie | Sale (S) | Common Stock | 17,470 | USD 4.75 | USD 82,982 | SEC filing ↗ |
| 2026-03-26 | Ugwumba Chidozie | Sale (S) | Common Stock | 5,319 | USD 5.40 | USD 28,723 | SEC filing ↗ |
| 2026-03-25 | Ugwumba Chidozie | Sale (S) | Common Stock | 7,098 | USD 5.50 | USD 39,039 | SEC filing ↗ |
| 2026-03-24 | Ugwumba Chidozie | Sale (S) | Common Stock | 5,492 | USD 5.78 | USD 31,744 | SEC filing ↗ |
| 2026-02-03 | Ugwumba Chidozie | Sale (S) | Common Stock | 5,559 | USD 4.10 | USD 22,792 | SEC filing ↗ |
| 2026-02-02 | Ugwumba Chidozie | Sale (S) | Common Stock | 3,800 | USD 4.04 | USD 15,352 | SEC filing ↗ |
| 2026-01-30 | Ugwumba Chidozie | Sale (S) | Common Stock | 5,686 | USD 4.13 | USD 23,483 | SEC filing ↗ |
| 2026-01-29 | Ugwumba Chidozie | Sale (S) | Common Stock | 15,284 | USD 4.32 | USD 66,027 | SEC filing ↗ |
| 2026-01-28 | Ugwumba Chidozie | Sale (S) | Common Stock | 8,717 | USD 4.91 | USD 42,800 | SEC filing ↗ |
| 2026-01-27 | Ugwumba Chidozie | Sale (S) | Common Stock | 4,139 | USD 5.08 | USD 21,026 | SEC filing ↗ |
| 2026-01-26 | Ugwumba Chidozie | Sale (S) | Common Stock | 6,418 | USD 5.02 | USD 32,218 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | CLNN |
| CIK | 0001822791 |
| Sector | Healthcare |
| Industry | Packaged Foods Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 152 transaction lines from 2021-05-24 to 2026-09-16 44 P purchase lines · 82 S sale lines · 26 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.